Postoperative Constipation and Ileus
After pelvic GU surgery, constipation, opioid-induced constipation (OIC), postoperative ileus and mechanical obstruction require different decisions. Assess oral tolerance, vomiting, pain, distension, flatus/stool, medication exposure and the operation performed. A patient with progressive symptoms should not simply move to the next laxative on a postoperative-day schedule.[1][2]
Bowel Preparation
The EAU recommends against preoperative bowel preparation for radical cystectomy. This is separate from standard antimicrobial prophylaxis. Planned colorectal resection has a different evidence base: ASCRS 2024 recommends oral antibiotics with mechanical bowel preparation (MBP) to reduce surgical-site infection; oral antibiotics alone are a conditional option when MBP is omitted or contraindicated.[3][4]
| Operation | Practical approach |
|---|---|
| Radical cystectomy with urinary diversion | No routine bowel preparation under the EAU pathway |
| GU operation without bowel entry | Do not import a colorectal preparation protocol solely because the operation is pelvic |
| Concomitant elective colorectal resection | Agree the colorectal preparation and systemic antibiotic plan with the colorectal team |
| Unusual colon-based reconstruction or complex fistula repair | Define the bowel procedure explicitly and individualize; use of a bowel segment alone does not establish benefit from MBP |
The 2025 NSQIP cystectomy analysis was observational and found different associations by diversion type; it does not establish that bowel preparation improves outcomes for all diversions.[5] See Bowel preparation for agents and safety.
Prevention and Recovery
Use an operation-specific enhanced-recovery pathway: opioid-sparing analgesia, appropriate hydration, correction of electrolyte abnormalities, early supported mobilization and early oral intake when clinically appropriate. Adapt analgesic choices to renal function, sedation risk and the reconstruction. No single drug combination is suitable for every patient.[6]
For uncomplicated elective colorectal surgery, ASCRS/SAGES recommends offering a regular diet within 24 hours and avoiding routine nasogastric decompression. These principles support early feeding after suitable GU bowel procedures, but established vomiting, obstruction or another complication requires reassessment. Chewing gum is an optional adjunct with small and inconsistent additional benefit within an established recovery pathway.[6]
When ongoing opioids are needed and bowel function permits laxatives, a stimulant and/or osmotic regimen can be started and titrated to the patient's baseline and response. Docusate alone is not a reliable prevention or treatment strategy. The supporting inpatient consensus primarily concerns medical patients; fresh bowel or rectal repairs need an individualized surgical plan.[7]
Alvimopan: plan before the operation
The US indication is acceleration of gastrointestinal recovery after surgery involving partial bowel resection with primary anastomosis. The labeled course starts before surgery, continues in hospital and is limited to seven days and 15 total doses under the REMS. It is contraindicated after therapeutic opioid use for more than seven consecutive days immediately before treatment. It is not a general rescue prescription for established postoperative ileus or chronic OIC.[8]
In the pivotal cystectomy trial, 280 patients were randomized and 277 entered the modified intention-to-treat analysis. Alvimopan shortened the composite time to solid-food tolerance plus bowel movement (5.5 versus 6.8 days) and length of stay (7.4 versus 10.1 days). The study largely involved open surgery and postoperative intravenous opioid analgesia. The Cochrane review was based on this same single trial, not independent confirmatory trials; it did not establish a cardiovascular safety advantage. Incremental benefit may differ with contemporary minimally invasive pathways.[9][10]
Opioid-Induced Constipation
OIC is new or worsening constipation associated with opioid exposure, including hard stool, straining and incomplete evacuation, not just infrequent bowel movements. Review other causes and the continuing opioid requirement. The AGA guideline mainly concerns patients with a prolonged opioid requirement; it is not a treatment protocol for unexplained immediate postoperative bowel dysfunction.[1]
| Situation | AGA recommendation |
|---|---|
| Confirmed OIC | Traditional laxatives first; optimize scheduled therapy before calling it refractory |
| Laxative-refractory OIC | Naldemedine or naloxegol recommended; methylnaltrexone conditionally suggested |
| Lubiprostone or prucalopride for OIC | No recommendation because of evidence gaps; not a guideline-defined third step |
Choose a prescription agent by the actual indication, interactions, organ function and route. Methylnaltrexone dosing and indications differ between chronic noncancer pain and advanced illness; oral and injected regimens are not interchangeable. Its label contraindicates use with known or suspected obstruction or increased recurrent-obstruction risk, warns about perforation in vulnerable bowel, and recognizes possible opioid withdrawal or reduced analgesia. Fresh postoperative distension should be evaluated before prescribing a PAMORA.[11]
Ileus Versus Mechanical Obstruction
Postoperative ileus is impaired propulsion without a mechanical blockage. Recovery varies with the procedure and patient; a fixed “normal through day three” or “image on day five” rule is unsafe. Mechanical obstruction can occur early, including before an apparent return of bowel function. Passing stool or diarrhea does not exclude incomplete obstruction.[2][12]
| Finding | Interpretation |
|---|---|
| Mild constipation with food tolerance and no progressive symptoms | Review medications, hydration and baseline bowel pattern; titrate a suitable laxative regimen |
| Persistent vomiting, increasing distension, focal or severe pain, systemic deterioration | Evaluate promptly for obstruction, leak, infection or another complication |
| Bowel sounds, plain radiograph, passage of a little stool | None reliably excludes a clinically important obstruction |
| CT | Can identify a transition point, hernia, closed loop or another cause; integrate with serial clinical assessment |
For suspected acute SBO, CT abdomen/pelvis with IV contrast is generally preferred when feasible. Oral contrast is not routinely needed for suspected high-grade obstruction and may delay assessment or increase vomiting/aspiration risk. A water-soluble contrast challenge is a separate, selected adhesive-obstruction pathway, not a prerequisite for urgent imaging.[2][13]
Management and Escalation
- Suspected ileus: reassess the cause, minimize contributing drugs, correct fluid/electrolyte problems and adjust intake to tolerance. Use nasogastric decompression for clinically significant vomiting/distension when needed, rather than routinely. Persistent or worsening symptoms need renewed investigation.[2][6]
- Mechanical obstruction: obtain early surgical review, resuscitate, withhold oral intake and decompress as appropriate. Some adhesive obstructions resolve without surgery. Peritonitis, strangulation, ischemia or a concerning closed loop require urgent operative assessment.[2]
- Timing: Bologna guidance supports a monitored trial of up to about 72 hours for uncomplicated adhesive SBO, with earlier escalation for deterioration. Early postoperative SBO is a distinct setting: the index operation and cause matter, and there is no agreed universal waiting interval. Do not turn historical 10–14-day observation into a default, especially for an incarcerated port-site or internal hernia.[2][12]
Agree rectal examination, suppositories, enemas or manual disimpaction with the operating team when these could disrupt a recent repair. An absent bowel movement alone is not an indication for a routine postoperative-day-three phosphate enema. Select rescue therapy after assessing the cause, hydration, renal function and the anatomy repaired.
Pharmacology Hub Companions
| Topic | Reference |
|---|---|
| Bowel-preparation agents, oral antibiotics and phosphate-related risks | Bowel preparation |
| Alvimopan labeling, laxatives and the separate acute-colonic-pseudo-obstruction pathway | Post-op bowel & ileus management |
| Multimodal recovery pathway | ERAS |
References
1. Crockett SD, Greer KB, Heidelbaugh JJ, et al. American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation. Gastroenterology. 2019;156:218–226. doi:10.1053/j.gastro.2018.07.016
2. ten Broek RPG, Krielen P, Di Saverio S, et al. Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2017 update. World J Emerg Surg. 2018;13:24. doi:10.1186/s13017-018-0185-2
3. European Association of Urology. Muscle-invasive and Metastatic Bladder Cancer guideline. Disease management: radical cystectomy and perioperative care. 2026. Official guideline.
4. Shogan BD, Vogel JD, Davis BR, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Preventing Surgical Site Infection. Dis Colon Rectum. 2024;67:1368–1382. doi:10.1097/DCR.0000000000003450
5. Simhal RK, McPartland C, Wang KR, et al. Bowel regimens before radical cystectomy: An analysis of a modern cohort. Int J Urol. 2025;32:402–408. doi:10.1111/iju.15668
6. Irani JL, Hedrick TL, Miller TE, et al. Clinical Practice Guidelines for Enhanced Recovery After Colon and Rectal Surgery From ASCRS and SAGES. Dis Colon Rectum. 2023;66:15–40. doi:10.1097/DCR.0000000000002650
7. Herzig SJ, Mosher HJ, Calcaterra SL, et al. Improving the Safety of Opioid Use for Acute Non-Cancer Pain in Hospitalized Adults: A Consensus Statement from the Society of Hospital Medicine. J Hosp Med. 2018;13:263–271. doi:10.12788/jhm.2980
8. Alvimopan. US prescribing information. DailyMed.
9. Lee CT, Chang SS, Kamat AM, et al. Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial. Eur Urol. 2014;66:265–272. doi:10.1016/j.eururo.2014.02.036
10. Sultan S, Coles B, Dahm P. Alvimopan for recovery of bowel function after radical cystectomy. Cochrane Database Syst Rev. 2017;5:CD012111. doi:10.1002/14651858.CD012111.pub2
11. RELISTOR (methylnaltrexone bromide). US prescribing information. DailyMed.
12. Ong AW, Myers SR. Early postoperative small bowel obstruction: A review. Am J Surg. 2020;219:535–539. doi:10.1016/j.amjsurg.2019.11.008
13. American College of Radiology. ACR Appropriateness Criteria: Suspected Small-Bowel Obstruction. Official narrative and imaging recommendations.